Industry litigation – Page 5
-
Business
US judge rules against GSK in trade secrets dispute
Firm will not receive compensation for claimed loses of over $1bn from theft of confidential information by two former scientists
-
Business
US supreme court will not hear J&J talc appeal
Decision means J&J must pay $2.1 billion previously awarded to 22 women who say talc caused their ovarian cancer
-
Business
US supreme court ends Sandoz–Amgen biosimilar dispute
Sandoz’s copy of arthritis drug Enbrel won’t be available in the US until 2029, 30 years after it was first marketed
-
Business
What might UK Reach look like?
As the UK’s legal system finds its feet post-Brexit, stakeholders have mixed feelings about the changes it could bring
-
Business
Coca-Cola chemist convicted of trade secret theft
Xiaorong You stole files detailing BPA-free can coatings from seven major chemicals firms
-
Opinion
A powerful blow against misconduct
Supporting whistleblowers is vital for detecting and preventing bad behaviour
-
Opinion
Rewards based on priority drive unnecessary competition
The story of Crispr illustrates how a focus on patents and publications can cause good people to act in unsavoury ways
-
Business
Patent applications listing AI as an inventor run into legal problems
Artificial intelligence is increasingly being used to find new chemical compounds and repurpose drugs, but should laws be updated to protect the intellectual property of such discoveries?
-
Business
DuPont and spinoffs reach $4bn settlement to resolve PFAS liability issues
DuPont, Chemours and Corteva have also reached an $83mn agreement to settle 95 pending personal injury cases in Ohio related to PFAS
-
Business
Brexit may put some chemicals out of GB’s Reach
Industry fears divergence of UK and EU regulations could spell disaster for trade
-
Business
Covid-19 highlights need to update pharma supply chains
Resilience and redundancy are key amid protectionist calls for domestic manufacturing
-
Business
Arkema acquitted over hurricane fire emissions
US Judge rules there is insufficient evidence to bring criminal charges relating to peroxide fire caused by flooding in 2017
-
Opinion
From collaboration to collusion
The US government’s crackdown on academics not declaring Chinese funding highlights a moral hazard
-
Business
Deadly Indian incidents highlight relaxed regulations
Concern over human and environmental cost of reforms aimed at ease of doing business
-
Business
Appeals court cuts damages further in glyphosate cancer case
Judgment retains verdict that Bayer-Monsanto’s herbicide caused US man’s cancer
-
Business
Bayer commits over $10bn to resolve legacy Monsanto lawsuits
Agreement settles about 75% of Roundup-related cases and resolves PCB and dicamba litigation
-
Business
3M slashes 1500 jobs globally
Reduction adds to 2000 layoffs announced in April, and is intended to save the company $110–120 million annually
-
Business
France to ban 36 glyphosate products by end of 2020
Move follows similar bans in several European states, with safety agency citing ‘absence of scientific data ruling out genotoxic risks’
-
Opinion
When should employees share profits from inventions?
Glucose monitor inventor wins £2m payout from Unilever after claiming his work provided ’outstanding benefit’
-
Business
Pharmaceuticals roundup 2019
Under the shadow of political turmoil and major lawsuits, the industry returned to its strengths – making new drugs, and finding new ways to do it better